newsfilter
← Latest News
GlobeNewswire·

Progenity Shares Two Poster Presentations on Treatment of Gastrointestinal Disorders at ECCO'22

SAN DIEGO, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (NASDAQ:PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today shared two poster presentations that were presented during